THE PHYSIOLOGICAL EFFECTS OF ELECTROMAGNETIC EMISSIONS ON THE GENERAL CONDITION OF THE PATIENT
- Conditions
- Electromagnetic Emissions and Emotional DisorderElectromagnetic Emissions and Medication Savings
- Registration Number
- NCT04301440
- Lead Sponsor
- Clinique Bizet
- Brief Summary
Hospital patients usually experience anxiety caused by physiological, psychological and environmental stimuli. This emotional state corresponds to the psychophysiological response to a perceived threat.
The investigator's goal is to use a non-drug approach to these problems which would help improve the quality of life of patients, prevent the consumption of anti-anxiety drugs / antidepressants; and thus to reduce the direct cost in terms of treatment, but also to reduce the indirect costs linked to work stoppages and the consumption of the care offer.
Working hypothesis: Local magnetic muscle stimulation improves people's well-being and relaxation
- Detailed Description
Primary objective :
Describe the effect of the intervention on the level of anxiety / depression in patients with anxious and / or depressive characteristics
Secondary objectives:
* Describe the variation in the quality of life of patients before and after the intervention
* Describe the variation in drug consumption
* Describe the use of post intervention hospitalization
* Describe the variation in the quality of sleep before and after the intervention
* Describe the timeframe for returning patients to professional activity
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 37
- Major patient hospitalized for the management of a chronic pathology and / or its complications;
- Patient with a Hospital Anxiety and Depression scale score (HAD) ≥ 8 for items assessing anxiety disorders; AND a HAD score ≥ 8 for the items assessing depressive disorders.
- Subject affiliated to a social security scheme or beneficiary of such a scheme
- No participation in another clinical study
- Minor patient
- Pregnant and breastfeeding women
- HAD score <8 for items evaluating anxiety disorders OR a HAD score <8 for items evaluating depressive disorders
- Major subject protected by law, under curatorship or tutorship
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Improved quality of life in depressed and anxiety patients: Hospital Anxiety and Depression scale Ten days Evaluation with Hospital Anxiety and Depression scale
Decreased consumption of anti-anxiety and anti-depressant drugs Ten days Prescription analysis
Improved quality of sleep: Epworth scale Ten days Evaluation with Epworth scale
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Benkessou
🇫🇷Paris, France
Benkessou🇫🇷Paris, France